ATLASATLAS fair value
₹4,539
Above fair value · 21% premium
Range: ₹2,796–₹7,367Fair valuePrice
Procter & Gamble Health (PGHL.NSE)
Procter & Gamble Health share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · National Stock Exchange of India · India
₹5,489▲ +8.56%
Prices as of Oct 27, 2026 · INR
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Procter & Gamble Health in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Procter & Gamble Health
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Procter & Gamble Health's fair value at about ₹4,539 per share (reasonable range: ₹2,796 to ₹7,367). At ₹5,489, the stock trades 21% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Procter & Gamble Health a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹5,234 and ₹5,783; in 9 out of 10, between ₹4,791 and ₹6,318. Estimated annual volatility is 30%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹85.2B
- Market cap (USD)
- $900M
- P/E ratio
- 23.2
- Dividend yield
- 1.71%
- 52-week high
- ₹6,975
- 52-week low
- ₹4,707
- Revenue (12 months)
- ₹14.3B
- Operating margin
- 25.7%
- Net margin
- 24.9%
- Beta
- 0.18
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Procter & Gamble Health sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks PGHL.NSE has traded between ₹4,707 and ₹6,975. Today it is 21.3% below that high and 17% above its low.
On the business: net margin is 24.9%; it trades at 23.2 times earnings.
Its beta is 0.18: it tends to move less than the market.
About the company
Procter & Gamble Health Ltd. is a major player in the pharmaceutical and healthcare sector, focusing on the development and distribution of a diverse range of healthcare solutions.
Want to see everything about Procter & Gamble Health?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Procter & Gamble Health (PGHL.NSE) fair value?
About ₹4,539 per share according to ATLAS (reasonable range: ₹2,796 to ₹7,367). With the stock at ₹5,489, it is 21% above it.
What is the chance PGHL.NSE goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, PGHL.NSE ends the month between ₹5,234 and ₹5,783.
How big is Procter & Gamble Health and what is its P/E ratio?
Procter & Gamble Health's market capitalization is ₹85.2B. Its price-to-earnings (P/E) ratio is 23.2: you pay ₹23.2 for each ₹1.00 of yearly earnings.
Does Procter & Gamble Health pay a dividend?
Yes. PGHL.NSE's current dividend yield is 1.71% at today's price (₹5,489).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer